The French National Healthcare Data System (SNDS) is Europe’s largest and most comprehensive healthcare database, covering over 65 million lives – approximately 99% of the French population. Certara is the first non-academic organization granted access to this anonymized dataset, enabling unparalleled real-world evidence (RWE) generation. Whether you seek to quantify unmet needs, demonstrate benefit/risk, or analyze treatment patterns, our expertise in SNDS empowers your strategic decisions.
French SNDS Real World Data Solutions
Access Europe’s largest source of real-world data and design studies
Identify treatment patterns and patient outcomes, uncover unmet needs for rare disease populations, and better understand resource utilization in clinical settings.
Learn more about Certara’s SNDS solutions and expertise
Leverage unmatched SNDS database expertise
for RWE studies
Comprehensive reach
Gain insights from a database covering more than 99% of the French population, ensuring robust and representative data analysis.
比類のない専門知識
Leverage decades of experience in real-world studies and advanced SNDS analysis for precise outcomes.
Advanced analytical methodologies
Link observational studies to advanced modeling in access data platforms built for bridging to real life studies.
Optimal rare disease research
Effectively study small populations for rare disease research by taking advantage of the universal nature, size and long follow-up time characteristic of France’s SNDS database.
サターラ：Your partner in SNDS data excellence
Real world solutions utilizing the French SNDS database
Evidence generation planning
Outcomes research and surveys
Burden of illness studies
Retrospective database studies
Chart reviews
Electronical medical record analytics
サターラの専門家
1 / 2
エキスパート
Ananth Kadambi, PhD
VP, Real World Evidence & Modeling Solutions
Ananth has more than 20 years’ experience in pharmaceutical consulting across a variety of disciplines, including quantitative systems pharmacology modeling, health economic modeling, systemic literature reviews, indirect treatment comparisons, and complex statistical analyses of clinical and real-world databases.
専門家に相談する
2 / 2
エキスパート
Nadia Quignot, PhD
Sr. Director, RWE & Modeling
Since joining Certara in 2013, Nadia has developed an extensive expertise in real-world evidence strategies and model-based analytics. She's led modeling initiatives and a range of real-world data analytics projects for European bodies and pharmaceutical companies, including directing 15+ French SNDS database projects.
専門家に相談する関連情報
全て見るお問合せはこちら
Partner with Certara to access and analyze the French SNDS database. Our unparalleled expertise in real-world evidence generation ensures impactful results, from identifying unmet needs to evaluating treatment outcomes.
Over 65 million lives covered by SNDS.
Decades of experience in real-world studies.
Pioneers in advanced SNDS methodologies.
お問合せはこちら
Discover related products and services
FAQs
What makes the SNDS database unique?
The SNDS database covers over 99% of the French population, offering comprehensive and representative healthcare data.
How does Certara ensure data quality?
We utilize advanced methodologies and robust study designs to minimize biases and maximize data utility.
Can SNDS data be used for rare disease studies?
Yes, the SNDS dataset’s size and long follow-up periods make it ideal for rare disease and drug-related adverse event research.
